Casdin Capital, LLC, Director, 10% Owner at GeneDx Holdings Corp. (WGS), bought 200,000 shares at $56.44 ($11.1M) on 2026-06-04, disclosed to the SEC on 2026-06-08.
Open-market purchase of $11.1M WGS by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.44 | 150,000 | $8.5M | 76.2% |
| 2 | $52.86 | 50,000 | $2.6M | 23.8% |
| Total | $55.55 avg | 200,000 | $11.1M | 100% |
| Filing → |
| BLFS | SELL | 2025-08-21 | $12.2M | — | Filing → |
| LAB | BUY | 2025-03-04 | $10.3M | — | Filing → |
| WGS | BUY | 2024-06-05 | $2.8M | — | Filing → |